Human BDCA-2 Protein (BCA-HM302)
Human BDCA-2 Protein (BCA-HM302)
Human BDCA-2 Protein (BCA-HM302)
  • Express System: HEK293
  • Product Tag: N-mFc
  • Purity: > 95% as determined by Bis-Tris PAGE
  • Activity: Immobilized Human BDCA-2, mFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-BDCA-2 Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA.
  • Amino Acid Range: Phe46-Ile213
Catalog #BCA-HM302
Regular price $346.50
/
Size
image image

Order by 4pm ET for delivery on:

Human BDCA-2 Protein (BCA-HM302) Summary

Product Description

Recombinant Human BDCA-2 Protein is expressed from HEK293 with mFc (IgG2a) tag at the N-Terminus.It contains Phe46-Ile213.

Product Background

BDCA-2 is a novel type II C-type lectin specifically expressed by plasmacytoid dendritic cells (PDCs) that can internalize antigen for presentation to T cells. Furthermore, signaling via BDCA-2 may play a role in switching from interferon (IFN)-α/β-controlled to interleukin (IL)-12-controlled immune response pathways, as triggering of BDCA-2 potently inhibits secretion of IFN-α/β by PDCs and thereby promotes IL-12 p70 production in PDCs and other cells.

Product Category

Recombinant Protein / Antibody discovery / Antibody discovery | Others

Human BDCA-2 Protein (BCA-HM302) Specifications/Details

Protein
BDCA-2
Synonyms
BDCA-2; BDCA2; CLECSF11; CLECSF7; DLEC; HECL; CLEC4C; CD303;
Accession
Species
Human
Biotinylated
no
Amino Acid Range
Phe46-Ile213
Molecular Weight
The protein has a predicted MW of 46.39 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Bis-Tris PAGE result.
Activity
Immobilized Human BDCA-2, mFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-BDCA-2 Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA.
Product Tag
N-mFc

Fluorophore

Unconjugated
Expression System
HEK293
Purity
> 95% as determined by Bis-Tris PAGE
Endotoxin
Less than 1 EU per ug by the LAL method.

Shipping, Reconstitution, & Storage

Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22 um filtered solution in 20mM Tris, 150mM NaCl, 200mM L-arginine (pH 8.5). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 ug or less, at 1mg/ml for 500ug or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Stability And Storage
-20 to -80°C for 12 months as supplied from date of receipt.;-80°C for 3 months after reconstitution.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Validation Images

Immobilized Human BDCA-2, mFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-BDCA-2 Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA. Immobilized Human BDCA-2, mFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-BDCA-2 Antibody, hFc Tag with the EC50 of 5.7ng/ml determined by ELISA.
Human BDCA-2 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Human BDCA-2 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Other Available Proteins:
Finding available proteins...
Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Recommended Products

Loading...
Recently viewed